Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael J Morris, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Michigan Health System
Ann Arbor, Michigan, United States
Maha Hussain, MD, FACPRecruiting - the Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
Tina Mayer, MDRecruiting - Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Michael J Morris, MDRecruiting - University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
Justine Y Bruce, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2011
- Primary completion
- 31 Aug 2012
- Completion
- 28 Feb 2015
- Last update posted
- 24 Jul 2012
- Registered enrollment
- 57
- Registry id
- NCT01296243
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.